American Century Companies’s Astria Therapeutics ATXS Stock Holding History

American Century Companies's ATXS Position: Q1 2026 in Review

American Century Companies sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 85,017 shares — an estimated $1.11M sold.

American Century Companies first reported a position in ATXS in Q3 2024 and held it in 6 quarters. The position peaked at $1.11M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

• American Century Companies reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
• American Century Companies sold 85,017 Astria Therapeutics shares in Q1 2026, an estimated $1.11M.
• American Century Companies first reported a position in Astria Therapeutics in Q3 2024 and held it in 6 quarters.
• American Century Companies's Astria Therapeutics position peaked at $1.11M in Q4 2025.
• 0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on American Century Companies's 13F filing for Q1 2026, filed 15 May 2026.